Filing Details
- Accession Number:
- 0001179110-21-001317
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-02-04 16:05:35
- Reporting Period:
- 2021-02-03
- Accepted Time:
- 2021-02-04 16:05:35
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1477449 | Teladoc Health Inc. | TDOC | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1375088 | C Adam Vandervoort | C/O Teladoc Health, Inc., 2 Manhattanville Road, Suite 203 Purchase NY 10577 | Chief Legal Officer, Secretary | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-02-03 | 1,446 | $22.30 | 1,646 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2021-02-03 | 1,164 | $38.55 | 2,810 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-02-03 | 2,610 | $269.85 | 200 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2021-02-03 | 1,446 | $0.00 | 1,446 | $22.30 |
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2021-02-03 | 1,164 | $0.00 | 1,164 | $38.55 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 1,447 | 2027-03-03 | No | 4 | M | Direct | |
| 15,223 | 2028-03-01 | No | 4 | M | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 16, 2020.
- The option vested as to 25% of the shares on March 3, 2018. The remainder of the shares vest in 36 equal monthly installments thereafter.
- The option vested as to 25% of the shares on March 1, 2019. The remainder of the shares vest in 36 equal monthly installments thereafter.
Billionaire Hedge Funds
